A comprehensive view of Biopharmaceuticals / Biologics. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Packaging Industry Market Intelligence Service.
CHMP recommends EU approval of Roche’s Alecensa monotherapy as the first adjuvant treatment for resected ALK-positive early-stage lung cancer; about half of people living with early-stage NSCLC experiencing disease recurrence or death following surgery
Published:
April 26, 2024
by F. Hoffmann-La Roche Ltd. (Roche)
|
Novavax Prepared to Deliver Protein-based Non-mRNA JN.1 COVID-19 Vaccine in Line with WHO Recommendation this Fall
Published:
April 26, 2024
by Novavax Inc.
|
Pfizer gains FDA approval for its gene therapy Beqvez for hemophilia B treatment, pricing it at US$3.5M, matching the cost of the world's most expensive drug, Hemgenix; the therapy aims to provide long-term benefits and potentially reduce costs
Published:
April 26, 2024
by FiercePharma
|
Pfizer Inc Secures Patent for Modulators of Sting (Stimulator of Interferon Genes)
Published:
April 26, 2024
by Pharmaceutical Patent News
|
CHMP adopts positive opinion recommending approval of Bristol Myers Squibb’s Opdivo nivolumab in combination with Cisplatin and Gemcitabine for the first-line treatment of adult patients with unresectable or metastatic urothelial carcinoma
Published:
April 26, 2024
by Bristol-Myers Squibb Co.
|
Ask us about our Packaging Industry market view